Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the efficacy and safety of anti-fibrinolytic and haemostatic drugs and agents in reducing bleeding and transfusion in people undergoing major vascular surgery or vascular procedures with a risk of moderate or severe (> 500 mL) blood loss.

Original publication

DOI

10.1002/14651858.CD013649

Type

Journal article

Journal

Cochrane Database of Systematic Reviews

Publication Date

01/07/2020

Volume

2020